Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gynecology

  Free Subscription


Articles published in Gynecol Endocrinol

Retrieve available abstracts of 225 articles:
HTML format
Text format



Single Articles


    July 2017
  1. PANDE AR, Guleria AK, Singh SD, Shukla M, et al
    beta cell function and insulin resistance in lean cases with polycystic ovary syndrome.
    Gynecol Endocrinol. 2017 Jul 13:1-5. doi: 10.1080/09513590.2017.1342165.
    PubMed     Text format     Abstract available


  2. ZHOU Y, Wang X, Jiang Y, Ma H, et al
    Association between polycystic ovary syndrome and the risk of stroke and all-cause mortality: insights from a meta-analysis.
    Gynecol Endocrinol. 2017 Jul 11:1-7. doi: 10.1080/09513590.2017.1347779.
    PubMed     Text format     Abstract available


  3. LUOTOLA K, Piltonen TT, Puurunen J, Morin-Papunen LC, et al
    Testosterone is associated with insulin resistance index independently of adiposity in women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2017 Jul 5:1-5. doi: 10.1080/09513590.2017.1342793.
    PubMed     Text format     Abstract available


  4. NERI C, Di Cesare C, Labianca A, Viggiano M, et al
    Obesity in pregnancy as a model to identify women at risk for later metabolic syndrome.
    Gynecol Endocrinol. 2017 Jul 4:1-4. doi: 10.1080/09513590.2017.1342792.
    PubMed     Text format     Abstract available


  5. LAMBRINOUDAKI I, Kazani A, Armeni E, Rizos D, et al
    The metabolic syndrome is associated with carotid atherosclerosis and arterial stiffness in asymptomatic, nondiabetic postmenopausal women.
    Gynecol Endocrinol. 2017 Jul 4:1-5. doi: 10.1080/09513590.2017.1344208.
    PubMed     Text format     Abstract available


    June 2017
  6. HUANG S, Qin J, Chen J, Cheng H, et al
    Impact of laparoscopy on the biological behavior and gene expression of endometrial adenocarcinoma cells.
    Gynecol Endocrinol. 2017 Jun 28:1-5. doi: 10.1080/09513590.2017.1342164.
    PubMed     Text format     Abstract available


  7. KIM SW, Kim H, Ku SY, Suh CS, et al
    A successful live birth with in vitro fertilization and thawed embryo transfer after conservative treatment of recurrent endometrial cancer.
    Gynecol Endocrinol. 2017 Jun 26:1-5. doi: 10.1080/09513590.2017.1342239.
    PubMed     Text format     Abstract available


  8. WU W, Fan X, Yu Y, Wang Z, et al
    Alteration of ghrelin/obestatin ratio in adolescence with polycystic ovarian syndrome.
    Gynecol Endocrinol. 2017 Jun 24:1-4. doi: 10.1080/09513590.2017.1336216.
    PubMed     Text format     Abstract available


  9. AL NOFAL A, Viers LD, Javed A
    Can the source of hyperandrogenism in adolescents with polycystic ovary syndrome predict metabolic phenotype?
    Gynecol Endocrinol. 2017 Jun 24:1-6. doi: 10.1080/09513590.2017.1342236.
    PubMed     Text format     Abstract available


  10. LEEAUNKULSATHEAN E, Pantasri T, Chaovisitseree S, Morakot N, et al
    The effect of different progestogens on sleep in postmenopausal women: a randomized trial.
    Gynecol Endocrinol. 2017 Jun 13:1-4. doi: 10.1080/09513590.2017.1333094.
    PubMed     Text format     Abstract available


  11. CZYZYK A, Latacz J, Filipowicz D, Podfigurna A, et al
    Severe hyperandrogenemia in postmenopausal woman as a presentation of ovarian hyperthecosis. Case report and mini review of the literature.
    Gynecol Endocrinol. 2017 Jun 11:1-4. doi: 10.1080/09513590.2017.1337094.
    PubMed     Text format     Abstract available


  12. PANKIEWICZ K, Szewczyk G, Maciejewski TM, Szukiewicz D, et al
    Strategies for overcoming oncological treatment-related ovarian dysfunction - literature review.
    Gynecol Endocrinol. 2017 Jun 11:1-6. doi: 10.1080/09513590.2017.1337095.
    PubMed     Text format     Abstract available


  13. SABBIONI L, Petraglia F, Luisi S
    Non-contraceptive benefits of intrauterine levonorgestrel administration: why not?
    Gynecol Endocrinol. 2017 Jun 6:1-8. doi: 10.1080/09513590.2017.1334198.
    PubMed     Text format     Abstract available


    May 2017
  14. ALVISI S, Baldassarre M, Martelli V, Gava G, et al
    Effects of ospemifene on vaginal epithelium of post-menopausal women.
    Gynecol Endocrinol. 2017 May 31:1-5. doi: 10.1080/09513590.2017.1332589.
    PubMed     Text format     Abstract available


  15. KAROUNTZOS V, Lambrinoudaki I, Tsitsika A, Deligeoroglou E, et al
    The role of total body fat mass and trunk fat mass, combined with other endocrine factors, in menstrual recovery and psychopathology of adolescents with Anorexia Nervosa.
    Gynecol Endocrinol. 2017 May 31:1-6. doi: 10.1080/09513590.2017.1334199.
    PubMed     Text format     Abstract available


  16. PALACIOS S, Lilue M, Mejia A, Menendez C, et al
    Omega-3 versus isoflavones in the control of vasomotor symptoms in postmenopausal women.
    Gynecol Endocrinol. 2017 May 31:1-7. doi: 10.1080/09513590.2017.1332588.
    PubMed     Text format     Abstract available


  17. LI W, Xue X, Zhao W, Ren A, et al
    Blastocyst transfer is not associated with increased unfavorable obstetric and perinatal outcomes compared with cleavage-stage embryo transfer.
    Gynecol Endocrinol. 2017 May 31:1-4. doi: 10.1080/09513590.2017.1332175.
    PubMed     Text format     Abstract available


  18. LIU C, Feng G, Huang W, Wang Q, et al
    Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial.
    Gynecol Endocrinol. 2017 May 30:1-5. doi: 10.1080/09513590.2017.1332174.
    PubMed     Text format     Abstract available


  19. ANDRISANI A, Dona G, Sabbadin C, Dall'Acqua S, et al
    Dapsone hydroxylamine-mediated alterations in human red blood cells from endometriotic patients.
    Gynecol Endocrinol. 2017 May 30:1-5. doi: 10.1080/09513590.2017.1332177.
    PubMed     Text format     Abstract available


  20. SARAF K, Tingi E, Brodison A, Sinha S, et al
    A rare case of primary ovarian carcinoid.
    Gynecol Endocrinol. 2017 May 20:1-4. doi: 10.1080/09513590.2017.1328049.
    PubMed     Text format     Abstract available


  21. ZHOU Q, Wu X, Dai X, Yuan R, et al
    The different dosages of estrogen affect endometrial fibrosis and receptivity, but not SDF-1/CXCR4 axis in the treatment of intrauterine adhesions.
    Gynecol Endocrinol. 2017 May 20:1-7. doi: 10.1080/09513590.2017.1328050.
    PubMed     Text format     Abstract available


  22. SILVA LA, Ferraz Carbonel AA, de Moraes ARB, Simoes RS, et al
    Collagen concentration on the facial skin of postmenopausal women after topical treatment with estradiol and genistein: a randomized double-blind controlled trial.
    Gynecol Endocrinol. 2017 May 16:1-4. doi: 10.1080/09513590.2017.1320708.
    PubMed     Text format     Abstract available


  23. SIRISTATIDIS C, Dafopoulos K, Christoforidis N, Anifandis G, et al
    Corifollitropin alfa compared with follitropin beta in GnRH-antagonist ovarian stimulation protocols in an unselected population undergoing IVF/ICSI.
    Gynecol Endocrinol. 2017 May 16:1-4. doi: 10.1080/09513590.2017.1323203.
    PubMed     Text format     Abstract available


  24. FAN Y, Zhang X, Hao Z, Ding H, et al
    Effectiveness of mild ovarian stimulation versus GnRH agonist protocol in women undergoing assisted reproductive technology: a meta-analysis.
    Gynecol Endocrinol. 2017 May 16:1-11. doi: 10.1080/09513590.2017.1320385.
    PubMed     Text format     Abstract available


  25. GIAMPAOLINO P, De Rosa N, Della Corte L, Morra I, et al
    Operative transvaginal hydrolaparoscopy improve ovulation rate after clomiphene failure in polycystic ovary syndrome.
    Gynecol Endocrinol. 2017 May 11:1-4. doi: 10.1080/09513590.2017.1323204.
    PubMed     Text format     Abstract available


  26. FRANK WOLF M, Peleg D, Stahl-Rosenzweig T, Kurzweil Y, et al
    Isolated polyhydramnios in the third trimester: is a gestational diabetes evaluation of value?
    Gynecol Endocrinol. 2017 May 10:1-4. doi: 10.1080/09513590.2017.1323857.
    PubMed     Text format     Abstract available


  27. MAMOLINI E, Cervellati C, Greco P, Carrieri A, et al
    VDR, RANKL and OPG polymorphisms as possible predisposing cofactors of postmenopausal osteoporosis: explorative study in Italian population.
    Gynecol Endocrinol. 2017 May 10:1-5. doi: 10.1080/09513590.2017.1323205.
    PubMed     Text format     Abstract available


  28. MASSAROTTI C, Fiorio P, Gastaldi R, Rosaia De Santis L, et al
    Controlled ovarian stimulation and IVF pregnancy in a trisomy X carrier with associated hypogonadotropic hypogonadism.
    Gynecol Endocrinol. 2017 May 9:1-3. doi: 10.1080/09513590.2017.1323202.
    PubMed     Text format     Abstract available


  29. NERI M, Malune ME, Corda V, Piras B, et al
    Body composition and psychological improvement in healthy premenopausal women assuming the oral contraceptive containing micronized estradiol (E2) and nomegestrol acetate (NOMAC).
    Gynecol Endocrinol. 2017 May 9:1-5. doi: 10.1080/09513590.2017.1322574.
    PubMed     Text format     Abstract available


  30. SEYAM E, Hasan M, Khalifa EM, Ramadan A, et al
    Evaluation of tumor necrosis factor alpha serum level in obese and lean women with clomiphene citrate-resistant polycystic ovary disease.
    Gynecol Endocrinol. 2017 May 8:1-7. doi: 10.1080/09513590.2017.1320383.
    PubMed     Text format     Abstract available


  31. PASTUSZEK E, Lukaszuk A, Kunicki M, Mockun J, et al
    New AMH assay allows rapid point of care measurements of ovarian reserve.
    Gynecol Endocrinol. 2017 May 1:1-6. doi: 10.1080/09513590.2017.1306735.
    PubMed     Text format     Abstract available


    April 2017
  32. DEMIR M, Ince O, Ozkan B, Kelekci S, et al
    Endometrial flushing alphaVbeta3 integrin, glycodelin and PGF2alpha levels for evaluating endometrial receptivity in women with polycystic ovary syndrome, myoma uteri and endometrioma.
    Gynecol Endocrinol. 2017 Apr 28:1-5. doi: 10.1080/09513590.2017.1318276.
    PubMed     Text format     Abstract available


  33. YANG X, Quan X, Lan Y, Ye J, et al
    Serum chemerin level during the first trimester of pregnancy and the risk of gestational diabetes mellitus.
    Gynecol Endocrinol. 2017 Apr 28:1-4. doi: 10.1080/09513590.2017.1320382.
    PubMed     Text format     Abstract available


  34. BHIDE P, Kulkarni A, Dilgil M, Dhir P, et al
    Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
    Gynecol Endocrinol. 2017 Apr 28:1-6. doi: 10.1080/09513590.2017.1320377.
    PubMed     Text format     Abstract available


  35. BAS-LANDO M, Rabinowitz R, Farkash R, Algur N, et al
    Prediction value of anti-Mullerian hormone (AMH) serum levels and antral follicle count (AFC) in hormonal contraceptive (HC) users and non-HC users undergoing IVF-PGD treatment.
    Gynecol Endocrinol. 2017 Apr 28:1-4. doi: 10.1080/09513590.2017.1320376.
    PubMed     Text format     Abstract available


  36. HOROWITZ E, Levran D, Weissman A
    Extension of the clomiphene citrate stair-step protocol to gonadotropin treatment in women with clomiphene resistant polycystic ovarian syndrome.
    Gynecol Endocrinol. 2017 Apr 28:1-4. doi: 10.1080/09513590.2017.1320381.
    PubMed     Text format     Abstract available


  37. COHADE C, Moreau J, Gatimel N, Gladieff L, et al
    Follicular growth but absence of oocyte and cumulus maturation during ovarian stimulation in the days following surgical abortion: a case report.
    Gynecol Endocrinol. 2017 Apr 28:1-2. doi: 10.1080/09513590.2017.1320386.
    PubMed     Text format     Abstract available


  38. BAKAS P, Simopoulou M, Giner M, Drakakis P, et al
    Predictive value of repeated measurements of luteal progesterone and estradiol levels in patients with intrauterine insemination and controlled ovarian stimulation.
    Gynecol Endocrinol. 2017 Apr 28:1-4. doi: 10.1080/09513590.2017.1320378.
    PubMed     Text format     Abstract available


  39. KEBAPCILAR AG, Ilhan TT, Dursunoglu D, Kebapcilar L, et al
    Efficacy comparison of oral rosuvastatin versus oral progesterone and bevacizumab on regression of surgically endometriotic implants in rats.
    Gynecol Endocrinol. 2017 Apr 28:1-5. doi: 10.1080/09513590.2017.1320384.
    PubMed     Text format     Abstract available


  40. YU Y, Li X, Jiang S, Jiang W, et al
    Serum thyroid hormone levels among Chinese pregnant women.
    Gynecol Endocrinol. 2017 Apr 27:1-5. doi: 10.1080/09513590.2017.1320375.
    PubMed     Text format     Abstract available


  41. LISS J, Kunicki M, Czyzyk A, Pastuszek E, et al
    Clinical utility of different anti-Mullerian hormone - AMH assays for the purpose of pregnancy prediction.
    Gynecol Endocrinol. 2017 Apr 27:1-6. doi: 10.1080/09513590.2017.1318370.
    PubMed     Text format     Abstract available


  42. NEJABATI HR, Latifi Z, Ghasemnejad T, Fattahi A, et al
    Placental growth factor (PlGF) as an angiogenic/inflammatory switcher: lesson from early pregnancy losses.
    Gynecol Endocrinol. 2017 Apr 27:1-7. doi: 10.1080/09513590.2017.1318375.
    PubMed     Text format     Abstract available


  43. LEVIN D, Hasson J, Cohen A, Or Y, et al
    The effect of endometrial injury on implantation and clinical pregnancy rates.
    Gynecol Endocrinol. 2017 Apr 27:1-4. doi: 10.1080/09513590.2017.1318369.
    PubMed     Text format     Abstract available


  44. MOURA FS, Costa-Barbosa FA, Leao SC, Nicolau SM, et al
    Confounder factors masking a Leydig-cell ovarian tumor in a post-menopausal woman treated for androgen-positive receptor breast cancer.
    Gynecol Endocrinol. 2017 Apr 26:1-5. doi: 10.1080/09513590.2017.1318373.
    PubMed     Text format     Abstract available


  45. YI L, Wei C, Fan W
    Fine particulate matter (PM2.5), a risk factor of rat gestational diabetes with altered blood glucose and pancreatic GLUT2 expression.
    Gynecol Endocrinol. 2017 Apr 25:1-6. doi: 10.1080/09513590.2017.1318368.
    PubMed     Text format     Abstract available


  46. PEREIRA N, Lekovich JP, Kligman I, Rosenwaks Z, et al
    Severe ovarian hyperstimulation syndrome after combined GnRH-agonist and low-dose human chorionic gonadotropin trigger in a patient with a single kidney.
    Gynecol Endocrinol. 2017 Apr 25:1-4. doi: 10.1080/09513590.2017.1318372.
    PubMed     Text format     Abstract available


  47. DE CICCO S, Immediata V, Romualdi D, Policola C, et al
    Myoinositol combined with alpha-lipoic acid may improve the clinical and endocrine features of polycystic ovary syndrome through an insulin-independent action.
    Gynecol Endocrinol. 2017 Apr 23:1-4. doi: 10.1080/09513590.2017.1313972.
    PubMed     Text format     Abstract available


  48. MOROTTI E, Casadio P, Guasina F, Battaglia B, et al
    Weight gain, body image and sexual function in young patients treated with contraceptive vaginal ring. A prospective pilot study.
    Gynecol Endocrinol. 2017 Apr 17:1-5. doi: 10.1080/09513590.2017.1306850.
    PubMed     Text format     Abstract available


  49. AKARSU S, Gode F, Isik AZ, Celenk H, et al
    Comparison of the morphokinetic parameters of embryos according to ovarian reserve in IVF cycles.
    Gynecol Endocrinol. 2017 Apr 17:1-4. doi: 10.1080/09513590.2017.1312327.
    PubMed     Text format     Abstract available


  50. GIAMPAOLINO P, Morra I, De Rosa N, Cagnacci A, et al
    Impact of transvaginal hydrolaparoscopy ovarian drilling on ovarian stromal blood flow and ovarian volume in clomiphene citrate-resistant PCOS patients: a case-control study.
    Gynecol Endocrinol. 2017 Apr 17:1-4. doi: 10.1080/09513590.2017.1310837.
    PubMed     Text format     Abstract available


  51. GRANDI G, Mueller MD, Bersinger NA, Facchinetti F, et al
    The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis.
    Gynecol Endocrinol. 2017 Apr 17:1-4. doi: 10.1080/09513590.2017.1314458.
    PubMed     Text format     Abstract available


  52. JIN J, Ruan X, Hua L, Tian X, et al
    Prevalence of diminished ovarian reserve in Chinese women with polycystic ovary syndrome and sensitive diagnostic parameters.
    Gynecol Endocrinol. 2017 Apr 17:1-4. doi: 10.1080/09513590.2017.1310838.
    PubMed     Text format     Abstract available


  53. DEPMANN M, Broer SL, Eijkemans MJ, van Rooij IA, et al
    Anti-Mullerian hormone does not predict time to pregnancy: results of a prospective cohort study.
    Gynecol Endocrinol. 2017 Apr 10:1-5. doi: 10.1080/09513590.2017.1306848.
    PubMed     Text format     Abstract available


  54. TSAI HW, Wang PH, Lin LT, Chen SN, et al
    Using gonadotropin-releasing hormone agonist before frozen embryo transfer may improve ongoing pregnancy rates in hyperandrogenic polycystic ovary syndrome women.
    Gynecol Endocrinol. 2017 Apr 10:1-4. doi: 10.1080/09513590.2017.1307961.
    PubMed     Text format     Abstract available


  55. YI L, Wei C, Fan W
    Fine-particulate matter (PM2.5), a risk factor for rat gestational diabetes with altered blood glucose and pancreatic GLUT2 expression.
    Gynecol Endocrinol. 2017 Apr 3:1-6. doi: 10.1080/09513590.2017.1301923.
    PubMed     Text format     Abstract available


    March 2017
  56. SOYLU KARAPINAR O, Pinar N, Ozcan O, Ozgur T, et al
    Protective effect of alpha-lipoic acid in methotrexate-induced ovarian oxidative injury and decreased ovarian reserve in rats.
    Gynecol Endocrinol. 2017 Mar 31:1-7. doi: 10.1080/09513590.2017.1306847.
    PubMed     Text format     Abstract available


  57. HARBECK B, Rahvar AH, Danneberg S, Schutt M, et al
    Life-threatening endocrine emergencies during pregnancy - management and therapeutic features.
    Gynecol Endocrinol. 2017 Mar 31:1-5. doi: 10.1080/09513590.2017.1307959.
    PubMed     Text format     Abstract available


  58. ZHANG Y, Lu JH, Zheng SY, Yan JH, et al
    Serum levels of nesfatin-1 are increased in gestational diabetes mellitus.
    Gynecol Endocrinol. 2017 Mar 31:1-4. doi: 10.1080/09513590.2017.1306849.
    PubMed     Text format     Abstract available


  59. FAIRBANKS F, Abdo CH, Baracat EC, Podgaec S, et al
    Endometriosis doubles the risk of sexual dysfunction: a cross-sectional study in a large amount of patients.
    Gynecol Endocrinol. 2017 Mar 28:1-4. doi: 10.1080/09513590.2017.1302421.
    PubMed     Text format     Abstract available


  60. PAPPA KI, Gazouli M, Anastasiou E, Loutradis D, et al
    The Q192R polymorphism of the paraoxonase-1 (PON1) gene is associated with susceptibility to gestational diabetes mellitus in the Greek population.
    Gynecol Endocrinol. 2017 Mar 28:1-4. doi: 10.1080/09513590.2017.1302419.
    PubMed     Text format     Abstract available


  61. FRANIK G, Lipka N, Kopyto K, Kopocinska J, et al
    Personality type influence the gestational weight gain.
    Gynecol Endocrinol. 2017 Mar 27:1-4. doi: 10.1080/09513590.2017.1302417.
    PubMed     Text format     Abstract available


  62. CIAVATTINI A, Delli Carpini G, Moriconi L, Clemente N, et al
    The association between ultrasound-estimated visceral fat deposition and uterine fibroids: an observational study.
    Gynecol Endocrinol. 2017 Mar 23:1-4. doi: 10.1080/09513590.2017.1302418.
    PubMed     Text format     Abstract available


  63. SANT'ANNA GD, Brum IS, Branchini G, Pizzolato LS, et al
    Ovarian steroid hormones modulate the expression of progesterone receptors and histone acetylation patterns in uterine leiomyoma cells.
    Gynecol Endocrinol. 2017 Mar 16:1-5. doi: 10.1080/09513590.2017.1301924.
    PubMed     Text format     Abstract available


  64. CHAVEZ B, Vilchis F, Rojano-Mejia D, Coral Vazquez RM, et al
    Association of CYP1A1 and CYP1B1 polymorphisms with bone mineral density variations in postmenopausal Mexican-Mestizo women.
    Gynecol Endocrinol. 2017 Mar 16:1-4. doi: 10.1080/09513590.2017.1301921.
    PubMed     Text format     Abstract available


  65. DAMBALA K, Vavilis D, Bili E, Goulis DG, et al
    Serum visfatin, vascular endothelial growth factor and matrix metalloproteinase-9 in women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2017 Mar 16:1-5. doi: 10.1080/09513590.2017.1296425.
    PubMed     Text format     Abstract available


  66. ASLIH N, Ellenbogen A, Shavit T, Michaeli M, et al
    Can we alter pregnancy outcome by adjusting progesterone treatment at mid-luteal phase: a randomized controlled trial.
    Gynecol Endocrinol. 2017 Mar 9:1-5. doi: 10.1080/09513590.2017.1298742.
    PubMed     Text format     Abstract available


  67. QUEIROZ VAZ G, Evangelista AV, Almeida Cardoso MC, Gallo P, et al
    Frozen embryo transfer cycles in women with deep endometriosis.
    Gynecol Endocrinol. 2017 Mar 7:1-4. doi: 10.1080/09513590.2017.1296945.
    PubMed     Text format     Abstract available


  68. TANMAHASAMUT P, Saejong R, Rattanachaiyanont M, Angsuwathana S, et al
    Postoperative desogestrel for pelvic endometriosis-related pain: a randomized controlled trial.
    Gynecol Endocrinol. 2017 Mar 7:1-6. doi: 10.1080/09513590.2017.1296124.
    PubMed     Text format     Abstract available


  69. MEDZA A, Obolonczyk L, Lewalska A, Buss T, et al
    Self-diagnosis of hyperparathyroidism during pregnancy resulting in parathyroidectomy and uncomplicated delivery.
    Gynecol Endocrinol. 2017 Mar 6:1-4. doi: 10.1080/09513590.2017.1296946.
    PubMed     Text format     Abstract available


  70. MONTELEONE P, Faviana P, Artini PG
    Thyroid peroxidase identified in human granulosa cells: another piece to the thyroid-ovary puzzle?
    Gynecol Endocrinol. 2017 Mar 5:1-3. doi: 10.1080/09513590.2017.1296424.
    PubMed     Text format     Abstract available


  71. SIRISTATIDIS C, Dafopoulos K, Vrantza T, Salamalekis G, et al
    Mild versus conventional antagonist ovarian stimulation protocols in expected normal responders undergoing IVF/ICSI: a case-control study.
    Gynecol Endocrinol. 2017 Mar 3:1-4. doi: 10.1080/09513590.2017.1296128.
    PubMed     Text format     Abstract available


  72. EMEKCI OZAY O, Ozay AC, Cagliyan E, Okyay RE, et al
    Myo-inositol administration positively effects ovulation induction and intrauterine insemination in patients with polycystic ovary syndrome: a prospective, controlled, randomized trial.
    Gynecol Endocrinol. 2017 Mar 3:1-5. doi: 10.1080/09513590.2017.1296127.
    PubMed     Text format     Abstract available


  73. DONG F, Zhang Q, Kong W, Chen J, et al
    Regulation of endometrial cell proliferation by estrogen-induced BDNF signaling pathway.
    Gynecol Endocrinol. 2017 Mar 2:1-5. doi: 10.1080/09513590.2017.1295439.
    PubMed     Text format     Abstract available


  74. HEALY M, Patounakis G, Zanelotti A, Devine K, et al
    Does premature elevated progesterone on the day of trigger increase spontaneous abortion rates in fresh and subsequent frozen embryo transfers?
    Gynecol Endocrinol. 2017 Mar 2:1-4. doi: 10.1080/09513590.2017.1291612.
    PubMed     Text format     Abstract available


  75. OZGEN SAYDAM B, Has AC, Bozdag G, Oguz KK, et al
    Structural imaging of the brain reveals decreased total brain and total gray matter volumes in obese but not in lean women with polycystic ovary syndrome compared to body mass index-matched counterparts.
    Gynecol Endocrinol. 2017 Mar 1:1-5. doi: 10.1080/09513590.2017.1295440.
    PubMed     Text format     Abstract available


    February 2017
  76. ZHAO Y, Ruan X, Mueck AO
    Letrozole combined with low dose highly purified HMG for ovulation induction in clomiphene citrate-resistant infertile Chinese women with polycystic ovary syndrome: a prospective study.
    Gynecol Endocrinol. 2017 Feb 28:1-5. doi: 10.1080/09513590.2017.1292241.
    PubMed     Text format     Abstract available


  77. CZYZYK A, Podfigurna A, Genazzani AR, Meczekalski B, et al
    The role of progesterone therapy in early pregnancy: from physiological role to therapeutic utility.
    Gynecol Endocrinol. 2017 Feb 28:1-4. doi: 10.1080/09513590.2017.1291615.
    PubMed     Text format     Abstract available


  78. SANG M, Wu X, Fan X, Lian Y, et al
    MAGE-A family serves as poor prognostic markers and potential therapeutic targets for epithelial ovarian cancer patients: a retrospective clinical study.
    Gynecol Endocrinol. 2017 Feb 28:1-5. doi: 10.1080/09513590.2017.1291611.
    PubMed     Text format     Abstract available


  79. XIA H, Zhang R, Sun X, Wang L, et al
    Valuable predictors of gestational diabetes mellitus in infertile Chinese women with polycystic ovary syndrome: a prospective cohort study.
    Gynecol Endocrinol. 2017 Feb 28:1-4. doi: 10.1080/09513590.2017.1290074.
    PubMed     Text format     Abstract available


  80. CZYZYK A, Filipowicz D, Podfigurna A, Ptas P, et al
    Brain-derived neurotrophic factor (BDNF) plasma concentration in patients diagnosed with premature ovarian insufficiency (POI).
    Gynecol Endocrinol. 2017 Feb 28:1-5. doi: 10.1080/09513590.2017.1290073.
    PubMed     Text format     Abstract available


  81. ZIELENIEWSKI W, Michalak R
    A successful case of pregnancy in a woman with ACTH-independent Cushing's syndrome treated with ketoconazole and metyrapone.
    Gynecol Endocrinol. 2017 Feb 26:1-4. doi: 10.1080/09513590.2017.1290070.
    PubMed     Text format     Abstract available


  82. USLUOGULLARI B, Usluogullari CA, Balkan F, Orkmez M, et al
    Role of serum levels of irisin and oxidative stress markers in pregnant women with and without gestational diabetes.
    Gynecol Endocrinol. 2017 Feb 26:1-3. doi: 10.1080/09513590.2017.1284789.
    PubMed     Text format     Abstract available


  83. OYARZUN MF, Castelo-Branco C
    Local hormone therapy for genitourinary syndrome of menopause in breast cancer patients: is it safe?
    Gynecol Endocrinol. 2017 Feb 21:1-3. doi: 10.1080/09513590.2017.1290076.
    PubMed     Text format     Abstract available


  84. JAMILIAN H, Jamilian M, Samimi M, Afshar Ebrahimi F, et al
    Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Gynecol Endocrinol. 2017 Feb 21:1-6. doi: 10.1080/09513590.2017.1290071.
    PubMed     Text format     Abstract available


  85. BAI X, Zhang Y, Liu S, Qu D, et al
    The decline in serum estradiol on the second day after oocyte retrieval affects the outcome of IVF/ICSI-ET treatment in high ovarian responders.
    Gynecol Endocrinol. 2017 Feb 21:1-6. doi: 10.1080/09513590.2017.1290069.
    PubMed     Text format     Abstract available


  86. HOU Z, Li M, Cao Y
    TCF7L2, CAPN10 polymorphisms are associated with gestational diabetes mellitus (GDM) risks: a meta-analysis.
    Gynecol Endocrinol. 2017 Feb 21:1-6. doi: 10.1080/09513590.2017.1290066.
    PubMed     Text format     Abstract available


  87. SEPAHI N, Kohan L, Jahromi AR, Daneshbod Y, et al
    mir-126 rs4636297 and TGFbetaRI rs334348 functional gene variants are associated with susceptibility to endometriosis and its severity.
    Gynecol Endocrinol. 2017 Feb 21:1-4. doi: 10.1080/09513590.2017.1290064.
    PubMed     Text format     Abstract available


  88. HERRERA-MUNOZ A, Fernandez-Alonso AM, Fischer-Suarez N, Chedraui P, et al
    Maternal serum cytokine levels in pregnancies complicated with threatened preterm labour.
    Gynecol Endocrinol. 2017 Feb 21:1-5. doi: 10.1080/09513590.2017.1284786.
    PubMed     Text format     Abstract available


  89. NAPPI RE, Particco M, Biglia N, Cagnacci A, et al
    Macro-regional variation in attitudes toward and experiences of vulvar and vaginal atrophy among Italian post-menopausal women: a post hoc analysis of REVIVE survey data.
    Gynecol Endocrinol. 2017 Feb 21:1-6. doi: 10.1080/09513590.2017.1284783.
    PubMed     Text format     Abstract available


  90. VALE FB, Coimbra BB, Lopes GP, Geber S, et al
    Sexual dysfunction in premenopausal women could be related to hormonal profile.
    Gynecol Endocrinol. 2017;33:145-147.
    PubMed     Text format     Abstract available


  91. TEMUR M, Yilmaz O, Aksun S, Calan M, et al
    The relationship of urocortin-2 with insulin resistance patients having PCOS.
    Gynecol Endocrinol. 2017;33:124-127.
    PubMed     Text format     Abstract available


    January 2017
  92. CUI N, Yang Y, Xu Y, Zhang J, et al
    Decreased expression of fatty acid amide hydrolase in women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2017 Jan 28:1-5. doi: 10.1080/09513590.2016.1269742.
    PubMed     Text format     Abstract available


  93. GUIDUCCI L, Maffei S, Sabatino L, Zyw L, et al
    Significance of the ionized calcium measurement to assess calcium status in osteopenic/osteoporosis postmenopausal outpatients.
    Gynecol Endocrinol. 2017 Jan 19:1-6. doi: 10.1080/09513590.2016.1270932.
    PubMed     Text format     Abstract available


  94. GUARINO A, Di Benedetto L, Giovanale V, Rampioni Vinciguerra GL, et al
    Hyperandrogenism in a postmenopausal woman: a rare case of ectopic adrenal cortical gland.
    Gynecol Endocrinol. 2017 Jan 19:1-3. doi: 10.1080/09513590.2016.1252326.
    PubMed     Text format     Abstract available


  95. BIANCHI C, Battini L, Aragona M, Lencioni C, et al
    Prescribing exercise for prevention and treatment of gestational diabetes: review of suggested recommendations.
    Gynecol Endocrinol. 2017 Jan 13:1-7. doi: 10.1080/09513590.2016.1266474.
    PubMed     Text format     Abstract available


  96. WILDEMEERSCH D, Goldstuck ND, Jackers G
    Results of a 5-year contraceptive trial in parous and nulliparous women with a new LNG-IUS.
    Gynecol Endocrinol. 2017 Jan 13:1-4. doi: 10.1080/09513590.2016.1276164.
    PubMed     Text format     Abstract available


  97. TARNOWSKI M, Malinowski D, Safranow K, Dziedziejko V, et al
    MTNR1A and MTNR1B gene polymorphisms in women with gestational diabetes.
    Gynecol Endocrinol. 2017 Jan 13:1-4. doi: 10.1080/09513590.2016.1276556.
    PubMed     Text format     Abstract available


  98. YIN D, Ruan X, Tian X, Du J, et al
    The relationship between thyroid function and metabolic changes in Chinese women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2017 Jan 4:1-4. doi: 10.1080/09513590.2016.1273895.
    PubMed     Text format     Abstract available


  99. DENG H, Li Z, Liu G, Li X, et al
    Elevated serum interferon gamma-inducible protein-10 in women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2017 Jan 4:1-5. doi: 10.1080/09513590.2016.1269740.
    PubMed     Text format     Abstract available


    December 2016
  100. DONG X, Yang L, Wang H
    miR-520 promotes DNA-damage-induced trophoblast cell apoptosis by targeting PARP1 in recurrent spontaneous abortion (RSA).
    Gynecol Endocrinol. 2016 Dec 31:1-5. doi: 10.1080/09513590.2016.1266476.
    PubMed     Text format     Abstract available


  101. PALMEROLA KL, Hsu JY, Grossman LC, Sauer MV, et al
    Repeated doses of GnRH antagonist at midcycle in artificial frozen embryo transfer cycles may not affect pregnancy outcomes.
    Gynecol Endocrinol. 2016 Dec 23:1-5. doi: 10.1080/09513590.2016.1266324.
    PubMed     Text format     Abstract available


  102. TARIQ S, Baig M, Tariq S, Shahzad M, et al
    Association of serum leptin with bone mineral density in postmenopausal osteoporotic females.
    Gynecol Endocrinol. 2016 Dec 23:1-5. doi: 10.1080/09513590.2016.1261103.
    PubMed     Text format     Abstract available


  103. LIU S, Hua T, Xin X, Shi R, et al
    Altered expression of hormone receptor, integrin beta3 and pinopode in the endometrium of luteal phase defect women.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  104. PONZANO A, Colangelo EC, Di Biase L, Romani F, et al
    Clinical experience with an ovarian stimulation protocol for intrauterine insemination adopting a gonadotropin releasing hormone antagonist at low dose.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  105. SAHIN Y, Ozkaya E, Kayatas Eser S, Kutlu T, et al
    Serum substance P concentrations to predict oocyte maturation index and clinical pregnancy.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  106. OZCAN DAG Z, Alpua M, Isik Y, Buturak SV, et al
    The evaluation of temperament and quality of life in patients with polycystic ovary syndrome.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  107. TANG YL, Yu J, Zeng ZG, Liu Y, et al
    Circulating omentin-1 levels in women with polycystic ovary syndrome: a meta-analysis.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  108. RASTOGI A, Bhadada SK, Bhansali A
    Pregnancy and tumor outcomes in infertile women with macroprolactinoma on cabergoline therapy.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  109. KARADAG C, Yoldemir T, Gogas Yavuz D
    Determinants of low bone mineral density in premenopausal polycystic ovary syndrome patients.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  110. ZANGENEH FZ, Naghizadeh MM, Bagheri M, Jafarabadi M, et al
    Are CRH & NGF as psychoneuroimmune regulators in women with polycystic ovary syndrome?
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  111. REMON-RUIZ P, Aliaga-Verdugo A, Guerrero-Vazquez R
    Pheochromocytoma in neurofibromatosis type 1 during pregnancy.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  112. GUIDA M, Di Carlo C, Troisi J, Gallo A, et al
    The sexuological impact of hormonal contraceptives based on their route of administration.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  113. LI YY, Ye SQ, Zhong ZH, Xu Q, et al
    Associations between maternal BMI as well as glucose tolerance and adverse pregnancy outcomes in women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  114. PERELMAN D, Coghlan N, Lamendola C, Carter S, et al
    Substituting poly- and mono-unsaturated fat for dietary carbohydrate reduces hyperinsulinemia in women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  115. SIRISTATIDIS C, Kreatsa M, Koutlaki N, Galazios G, et al
    Endometrial injury for RIF patients undergoing IVF/ICSI: a prospective nonrandomized controlled trial.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  116. PERDOMO CM, Arabe JA, Idoate MA, Galofre JC, et al
    Management of a pregnant woman with thyrotropinoma: a case report and review of the literature.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  117. D'ANNA R, Santamaria A, Giorgianni G, Vaiarelli A, et al
    Myo-inositol and melatonin in the menopausal transition.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  118. GIRALDO H, Benetti-Pinto C, Ferreira V, Garmes H, et al
    Standard hormone therapy is inadequate for bone density in premature ovarian insufficiency.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  119. KORSHOLM AS, Hvidman HW, Bentzen JG, Nyboe Andersen A, et al
    Left-right differences in ovarian volume and antral follicle count in 1423 women of reproductive age.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  120. GARRIDO OYARZUN MF, Castelo-Branco C
    Sexuality and quality of life in congenital hypogonadisms.
    Gynecol Endocrinol. 2016;32:947-950.
    PubMed     Text format     Abstract available


  121. CEHIC E, Kasum M, Simunic V, Oreskovic S, et al
    Fertility in men with spinal cord injury.
    Gynecol Endocrinol. 2016;32:937-941.
    PubMed     Text format     Abstract available


    November 2016
  122. VILLARROEL C, Salinas A, Lopez P, Kohen P, et al
    Pregestational type 2 diabetes and gestational diabetes exhibit different sexual steroid profiles during pregnancy.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  123. ZHU HY, Liu S, He D, Zhou WH, et al
    Serum luteinizing hormone level on the third day after ovarian stimulation in GnRH agonist short protocol is predictive of outcome in poor responders but not in normal responders.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  124. MONASTRA G, Unfer V, Harrath AH, Bizzarri M, et al
    Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  125. GARRIDO OYARZUN MF, Castelo-Branco C
    Use of hormone therapy for menopausal symptoms and quality of life in breast cancer survivors. Safe and ethical?
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  126. YANG Z, Hu Y, Zhang J, Xu L, et al
    Estradiol therapy and breast cancer risk in perimenopausal and postmenopausal women: a systematic review and meta-analysis.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  127. CIAVATTINI A, Serri M, Delli Carpini G, Morini S, et al
    Ovarian endometriosis and vitamin D serum levels.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  128. BASTIANELLI C, Farris M, Bruno Vecchio RC, Rosato E, et al
    An observational study of adherence to combined oral contraceptive regimens.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  129. ALBERICHE M, Sanchez-Hernandez RM, Lopez Merida X, Wagner AM, et al
    Onset of Graves' disease during pregnancy in a woman with established hypothyroidism.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  130. ABDEL RAZIK M, El-Berry S, El-Nezamy A, Saad A, et al
    Nitric oxide donors increase the pregnancy rate in patients with unexplained infertility undergoing clomiphene citrate stimulation and intrauterine insemination: a randomized controlled pilot study.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  131. PROCOPCIUC LM, Caracostea G, Hazi G, Nemeti G, et al
    D2-Thr92Ala, thyroid hormone levels and biochemical hypothyroidism in preeclampsia.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  132. PAREDES V, Espinoza-Caicedo JA, Salazar-Pousada D, Escobar GS, et al
    Lower placental growth factor and higher free beta-hCG and PAPP-A levels in the fetal circulation of near-term pregnancies complicated with severe preeclampsia.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  133. KJAER MM, Madsbad S, Hougaard DM, Cohen AS, et al
    The impact of gastric bypass surgery on sex hormones and menstrual cycles in premenopausal women.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  134. FRUZZETTI F, Perini D, Russo M, Bucci F, et al
    Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS).
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  135. KAWANO M, Komura H, Kawaguchi H, Shimizu S, et al
    Ovarian insufficiency following allogeneic hematopoietic stem cell transplantation.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  136. TINGI E, Kyriacou A, Verghese L
    Recurrence of phaeochromocytoma in pregnancy in a patient with multiple endocrine neoplasia 2A: a case report and review of literature.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  137. AYDIN HA, Derbent Uysal A, Erol O, Ellidag HY, et al
    The association between serum ghrelin levels and large-for-gestational-age fetuses in patients with gestational diabetes mellitus.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  138. ASKEROV R
    Embryoscopic diagnostics of endometrial defects in missed abortion after IVF.
    Gynecol Endocrinol. 2016;32.
    PubMed     Text format     Abstract available


  139. SHESTAKOVA IG, Radzinsky VE, Khamoshina MB
    Occult form of premature ovarian insufficiency.
    Gynecol Endocrinol. 2016;32.
    PubMed     Text format     Abstract available


  140. KRYLOVA Y, Polyakova V, Kvetnoy I, Kogan I, et al
    Immunohistochemical criteria for endometrial receptivity in I/II stage endometriosis IVF-treated patients.
    Gynecol Endocrinol. 2016;32.
    PubMed     Text format     Abstract available


  141. LISOVSKAYA TV, Mal'gina GB, Perepletina TA, Chistyakov MA, et al
    Morphological characteristics of endometrium in patients of reproductive age with viral hepatitis type C.
    Gynecol Endocrinol. 2016;32.
    PubMed     Text format     Abstract available


  142. MAMEDALIYEVA NM, Issenova SS, Lokshin VN
    Study of polymorphic variants of the TNF gene in pregnant women with mycoplasma infection in the Kazakh population.
    Gynecol Endocrinol. 2016;32.
    PubMed     Text format     Abstract available


  143. DERYABINA EG, Yakornova GV, Pestryaeva LA, Sandyreva ND, et al
    Perinatal outcome in pregnancies complicated with gestational diabetes mellitus and very preterm birth: case-control study.
    Gynecol Endocrinol. 2016;32.
    PubMed     Text format     Abstract available


  144. SHEVELEVA T, Bejenar V, Komlichenko E, Dedul A, et al
    Innovative approach in assessing the role of neurogenesis, angiogenesis, and lymphangiogenesis in the pathogenesis of external genital endometriosis.
    Gynecol Endocrinol. 2016;32.
    PubMed     Text format     Abstract available


  145. MELKOZEROVA OA, Bashmakova NV, Volkova EV, Tretyakova TB, et al
    The molecular and genetic aspects of adolescent girls anomalous uterine bleeding: the role of endothelial dysfunction syndrome.
    Gynecol Endocrinol. 2016;32.
    PubMed     Text format     Abstract available


  146. MULLER V, Makhmadalieva M, Kogan I, Fedorova I, et al
    Ectopic pregnancy following in vitro fertilization: meta-analysis and single-center experience during 6 years.
    Gynecol Endocrinol. 2016;32.
    PubMed     Text format     Abstract available


  147. MAMEDALIEVA NM, Kurmanova AM, Moshkalova GN, Kim V, et al
    Local immunity status in patients with miscarriages and herpetic infection.
    Gynecol Endocrinol. 2016;32.
    PubMed     Text format     Abstract available


  148. BASHMAKOVA NV, Davydenko NB, Malgina GB, Putilova NV, et al
    Epidemiology of critical states during pregnancy after assisted reproductive technologies.
    Gynecol Endocrinol. 2016;32.
    PubMed     Text format     Abstract available


  149. PATEL AP, Patel JA, Cruz M, Gupte-Shah A, et al
    Ethnicity is an independent predictor of IVF-ICSI outcome: a study of 5,549 cycles in Spain and India.
    Gynecol Endocrinol. 2016;32:819-822.
    PubMed     Text format     Abstract available


  150. BHANDARI S, Ganguly I, Bhandari M, Agarwal P, et al
    Effect of sleeve gastrectomy bariatric surgery-induced weight loss on serum AMH levels in reproductive aged women.
    Gynecol Endocrinol. 2016;32:799-802.
    PubMed     Text format     Abstract available


    September 2016
  151. HUGON-RODIN J, Kalhorpour N, Borghese B, Bordonne C, et al
    Inhibin A and inhibin B producing ovarian fibrothecoma revealed by suppression of follicle stimulating hormone (FSH) in a post-menopausal woman: report of the first case.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  152. SHARIFZADEH F, Aminimoghaddam S, Kashanian M, Fazaeli M, et al
    A comparison between the effects of metformin and megestrol on simple endometrial hyperplasia.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  153. NEVES-E-CASTRO M
    Is there a menopausal medicine?
    Gynecol Endocrinol. 2016.
    PubMed     Text format    


  154. KOREN R, Ashwal E, Hod M, Toledano Y, et al
    Insulin detemir versus glyburide in women with gestational diabetes mellitus.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  155. SIMONCIG NETJASOV A, Tancic-Gajic M, Ivovic M, Marina L, et al
    Influence of obesity and hormone disturbances on sexuality of women in the menopause.
    Gynecol Endocrinol. 2016;32:762-766.
    PubMed     Text format     Abstract available


    August 2016
  156. HE SJ, Chan C, Xie ZD, Shi D, et al
    The relationship between serum uric acid and metabolic syndrome in premenopausal and postmenopausal women in the Jinchang Cohort.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  157. TALEB-BELKADI O, Chaib H, Zemour L, Fatah A, et al
    Lipid profile, inflammation, and oxidative status in peri- and postmenopausal women.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  158. QIU XY, Sun L, Han XL, Chang Y, et al
    Alarmin high mobility group box-1 in maternal serum as a potential biomarker of chorioamnionitis-associated preterm birth.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  159. CSENTERI OK, Sandor J, Kalina E, Bhattoa HP, et al
    The role of hyperinsulinemia as a cardiometabolic risk factor independent of obesity in polycystic ovary syndrome.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  160. HAN AR, Lee TH, Kim S, Lee HY, et al
    Risk factors and biomarkers for the recurrence of ovarian endometrioma: about the immunoreactivity of progesterone receptor isoform B and nuclear factor kappa B.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  161. HUANG P, Wei L, Li X
    A study of intrauterine infusion of human chorionic gonadotropin (hCG) before frozen-thawed embryo transfer after two or more implantation failures.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  162. WANG Q, Zhang R, Jia M, Luo L, et al
    Serum human chorionic gonadotropin measured 7 days following day 3 embryo transfer might predict pregnancy outcome in IVF.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  163. ZHANG H, Li H, Qi S, Liu Z, et al
    Normal endometrial stromal cells regulate 17beta-estradiol-induced epithelial-mesenchymal transition via slug and E-cadherin in endometrial adenocarcinoma cells in vitro.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  164. MAGED AM, Abdelhafiz A, Mostafa WA, El-Nassery N, et al
    The role of prophylactic use of low dose aspirin and calheparin in patients with unexplained recurrent abortion.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  165. GINGOLD JA, Zafman K, Rodriguez-Purata J, Whitehouse MC, et al
    Do elevated TSH levels predict early pregnancy loss in ART patients?
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  166. RUDNICKA E, Radowicki S, Suchta K
    Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome - a new insight.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  167. DING N, Chang J, Jian Q, Liang X, et al
    Luteal phase clomiphene citrate for ovulation induction in women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  168. LI S, Zhu D, Duan H, Tan Q, et al
    The epigenomics of polycystic ovarian syndrome: from pathogenesis to clinical manifestations.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  169. FROSSING S, Nylander M, Aziz M, Skouby SO, et al
    Atrial natriuretic peptide, copeptin and adrenomedullin levels in polycystic ovary syndrome: a case-control study.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  170. BOGDANOU D, Meyer G, Stuecker AU, Thalhammer A, et al
    A rare case of an androgen-producing stromal luteoma of the ovary in a postmenopausal woman, diagnosed by means of selective venous blood sampling.
    Gynecol Endocrinol. 2016.
    PubMed     Text format    


  171. FRANIK G, Krysta K, Madej P, Gimlewicz-Pieta B, et al
    Sleep disturbances in women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  172. SEIKKULA J, Anttila L, Polo-Kantola P, Bloigu R, et al
    Effect of mid-luteal phase GnRH agonist on frozen-thawed embryo transfers during natural menstrual cycles: a randomised clinical pilot study.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  173. KARACA A, Omma T, Dura Deveci C, Bakar F, et al
    Neopterin and hsCRP are not correlated in gestational diabetes mellitus.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  174. TOKMAK A, Kokanali D, Timur H, Kuntay Kokanali M, et al
    Association between anti-Mullerian hormone and insulin resistance in non-obese adolescent females with polycystic ovary syndrome.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  175. DUMONT A, Dewailly D, Plouvier P, Catteau-Jonard S, et al
    Comparison between pulsatile GnRH therapy and gonadotropins for ovulation induction in women with both functional hypothalamic amenorrhea and polycystic ovarian morphology.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  176. SEVAL MM, Sukur YE, Ozmen B, Berker B, et al
    Does adding endometrial scratching to diagnostic hysteroscopy improve pregnancy rates in women with recurrent in-vitro fertilization failure?
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  177. DUAN L, Wang J, Sun X, Yang X, et al
    The role and significance of endomorphin-1 and mu-opioid receptor in rats with endometriosis.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  178. ZHENG Q, Lu J, Li R, Hu C, et al
    Elevated periostin in serum and peritoneal washing fluids as potential biomarkers for endometriosis.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  179. SPINELLI C, Strambi S, Liloia C, Bertocchini A, et al
    Update on the surgical management of ovarian neoplasms in children and adolescents: analysis on 32 cases.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  180. GOZUKARA I, Dokuyucu R, Ozgur T, Ozcan O, et al
    Histopathologic and metabolic effect of ursodeoxycholic acid treatment on PCOS rat model.
    Gynecol Endocrinol. 2016;32:492-7.
    PubMed     Text format     Abstract available


  181. ZEBITAY AG, Tutumlu M, Verit FF, Ilhan GK, et al
    A comparative analysis of arterial blood flow in unexplained infertility, tubal infertility and fertile groups.
    Gynecol Endocrinol. 2016;32:442-5.
    PubMed     Text format     Abstract available


    May 2016
  182. GOKKAYA N, Gungor A, Bilen A, Bilen H, et al
    Primary hyperparathyroidism in pregnancy: a case series and literature review.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  183. GIAMPAOLINO P, Morra I, Della Corte L, Sparice S, et al
    Serum anti-Mullerian hormone levels after ovarian drilling for the second-line treatment of polycystic ovary syndrome: a pilot-randomized study comparing laparoscopy and transvaginal hydrolaparoscopy.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  184. PARADISI R, Macciocca M, Vicenti R, Rossi S, et al
    New insights in the selection and management of cancer patients applicants for ovarian tissue cryopreservation.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  185. LAMBRINOUDAKI I, Augoulea A, Rizos D, Politi M, et al
    Greek-origin royal jelly improves the lipid profile of postmenopausal women.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  186. HU W, Chen L, Mao S, Qiao J, et al
    A case-control study on reduced HDL2b in patients with polycystic ovarian syndrome.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  187. KITSOU C, Kosmas I, Lazaros L, Tzallas C, et al
    The combination of Everolimus with Verapamil reduces ovarian weight and vascular permeability on ovarian hyperstimulation syndrome: a preclinical experimental randomized controlled study.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  188. PARK SY, Kim HJ, Lee SR, Choi YH, et al
    Black cohosh inhibits 17beta-estradiol-induced cell proliferation of endometrial adenocarcinoma cells.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  189. SADRZADEH S, Painter RC, Lambalk CB
    Developmental origins of polycystic ovary syndrome (PCOS), a case control study comparing birth weight in women with PCOS and control group.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  190. WANG Y, Zhu Q, Dang X, He Y, et al
    Local effect of bisphenol A on the estradiol synthesis of ovarian granulosa cells from PCOS.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  191. CORTES-BONILLA M, Alonso-Campero R, Bernardo-Escudero R, Francisco-Doce MT, et al
    Improvement of quality of life and menopausal symptoms in climacteric women treated with low-dose monthly parenteral formulations of non-polymeric microspheres of 17beta-estradiol/progesterone.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  192. ZHAO X, Zhang XF, Zhao Y, Lin X, et al
    Effect of combined drospirenone with estradiol for hypertensive postmenopausal women: a systemic review and meta-analysis.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  193. LUO L, Wang Q, Chen M, Yuan G, et al
    IGF-1 and IGFBP-1 in peripheral blood and decidua of early miscarriages with euploid embryos: comparison between women with and without PCOS.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  194. LU YH, Xia ZL, Ma YY, Chen HJ, et al
    Subclinical hypothyroidism is associated with metabolic syndrome and clomiphene citrate resistance in women with polycystic ovary syndrome.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


  195. KUCUKLER FK, Gorkem U, Simsek Y, Kocabas R, et al
    Low level of Nesfatin-1 is associated with gestational diabetes mellitus.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  196. DEMIR B, Bozdag G, Sengul O, Kahyaoglu I, et al
    The impact of unilateral salpingectomy on antral follicle count and ovarian response in ICSI cycles: comparison of contralateral side.
    Gynecol Endocrinol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  197. FIORIO P, Rosaia De Santis L, Cuoco C, Gimelli G, et al
    Hypogonadotropic hypogonadism in a trisomy X carrier: phenotype description and genotype correlation.
    Gynecol Endocrinol. 2016;32:14-7.
    PubMed     Text format     Abstract available


  198. VAIARELLI A, Drakopoulos P, Blockeel C, De Vos M, et al
    Limited ability of circulating anti-Mullerian hormone to predict dominant follicular recruitment in PCOS women treated with clomiphene citrate: a comparison of two different assays.
    Gynecol Endocrinol. 2016;32:227-30.
    PubMed     Text format     Abstract available


  199. MARCHAND L, Chabert P, Chaudesaygues E, Grasse M, et al
    An unusual cause of cardiothyreosis.
    Gynecol Endocrinol. 2016;32:107-9.
    PubMed     Text format     Abstract available


  200. LARA-DOMINGUEZ MD, Arjona-Berral JE, Dios-Palomares R, Castelo-Branco C, et al
    Outpatient hysteroscopic polypectomy: bipolar energy system (Versapoint(R)) versus diode laser - randomized clinical trial.
    Gynecol Endocrinol. 2016;32:196-200.
    PubMed     Text format     Abstract available


  201. LORENTE GONZALEZ J, Rios Castillo JE, Pomares Toro E, Romero Nieto MI, et al
    Essure a novel option for the treatment of hydrosalpinx: a case series and literature review.
    Gynecol Endocrinol. 2016;32:166-70.
    PubMed     Text format     Abstract available


  202. PACCHIAROTTI A, Carlomagno G, Antonini G, Pacchiarotti A, et al
    Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome.
    Gynecol Endocrinol. 2016;32:69-73.
    PubMed     Text format     Abstract available


  203. XIROFOTOS D, Trakakis E, Peppa M, Chrelias C, et al
    The amount and duration of smoking is associated with aggravation of hormone and biochemical profile in women with PCOS.
    Gynecol Endocrinol. 2016;32:143-6.
    PubMed     Text format     Abstract available


  204. FENG W, Jia YY, Zhang DY, Shi HR, et al
    Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin.
    Gynecol Endocrinol. 2016;32:147-50.
    PubMed     Text format     Abstract available


  205. IMAI A, Matsunami K, Ichigo S, Takagi H, et al
    Minodronic acid suppresses gonadotropin-releasing hormone agonist-induced bone remodeling biomarkers: a retrospective pilot study.
    Gynecol Endocrinol. 2016;32:250-2.
    PubMed     Text format     Abstract available


  206. ZHENG SH, Li XL
    Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS.
    Gynecol Endocrinol. 2016;32:177-83.
    PubMed     Text format     Abstract available


  207. HUANG L, Wang S, Ma Y
    Combined evaluation of risk factors predicting poor ovarian responders in Chinese patients undergoing in vitro fertilization.
    Gynecol Endocrinol. 2016;32:124-7.
    PubMed     Text format     Abstract available


  208. SHAHBAZI S, Shahrabi-Farahani M
    Evaluation of the correlation between body mass index and endometriosis among Iranian fertile women.
    Gynecol Endocrinol. 2016;32:157-60.
    PubMed     Text format     Abstract available


  209. TEMUR M, Yilmaz O, Aksun S, Ozun Ozbay P, et al
    Increased circulating urocortin-3 levels is associated with polycystic ovary syndrome.
    Gynecol Endocrinol. 2016;32:218-22.
    PubMed     Text format     Abstract available


  210. GURBUZ AS, Deveer R, Ozcimen N, Ozcimen EE, et al
    Absence of luteal phase defect and spontaneous pregnancy in IVF patients despite GnRH-agonist trigger and "freeze all policy" without luteal phase support: a report of four cases.
    Gynecol Endocrinol. 2016;32:18-20.
    PubMed     Text format     Abstract available


  211. JEDRZEJUK D, Lwow F, Kuliczkowska-Plaksej J, Hirnle L, et al
    Association of serum glypican-4 levels with cardiovascular risk predictors in women with polycystic ovary syndrome - a pilot study.
    Gynecol Endocrinol. 2016;32:223-6.
    PubMed     Text format     Abstract available


  212. AKTUN HL, Yorgunlar B, Acet M, Aygun BK, et al
    The effects of polycystic ovary syndrome on gestational diabetes mellitus.
    Gynecol Endocrinol. 2016;32:139-42.
    PubMed     Text format     Abstract available


  213. CHAN Y, Jiang H, Yang X, Li D, et al
    Polymorphism of MDM2 promoter 309 (rs 2279744) and the risk of PCOS.
    Gynecol Endocrinol. 2016;32:136-8.
    PubMed     Text format     Abstract available


  214. FETTBACK PB, Pereira RM, Rocha AM, Soares JM Jr, et al
    Expression of stem cell-related genes in the endometrium and endometriotic lesions: a pilot study.
    Gynecol Endocrinol. 2016;32:82-6.
    PubMed     Text format     Abstract available


  215. DIRI H, Karaburgu S, Acmaz B, Unluhizarci K, et al
    Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome.
    Gynecol Endocrinol. 2016;32:42-5.
    PubMed     Text format     Abstract available


  216. TASKIN MI, Eser B, Adali E, Kara H, et al
    NUCB2 gene polymorphism and its relationship with nesfatin-1 levels in polycystic ovary syndrome.
    Gynecol Endocrinol. 2016;32:46-50.
    PubMed     Text format     Abstract available


  217. NAPPI L, Angioni S, Sorrentino F, Cinnella G, et al
    Anti-Mullerian hormone trend evaluation after laparoscopic surgery of monolateral endometrioma using a new dual wavelengths laser system (DWLS) for hemostasis.
    Gynecol Endocrinol. 2016;32:34-7.
    PubMed     Text format     Abstract available


  218. YANG S, Wang Q, Huang W, Song Y, et al
    Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
    Gynecol Endocrinol. 2016;32:38-41.
    PubMed     Text format     Abstract available


  219. WATROWSKI R, Rohde A, Maciejewska-Jeske M, Meczekalski B, et al
    Hormonal and psychosocial correlates of psychological well-being and negative affectivity in young gynecological-endocrinological patients.
    Gynecol Endocrinol. 2016;32:21-4.
    PubMed     Text format     Abstract available


  220. LAGANA AS, Giacobbe V, Triolo O, Granese R, et al
    Dienogest as preoperative treatment of submucous myomas for hysteroscopic surgery: a prospective, randomized study.
    Gynecol Endocrinol. 2016;32:408-11.
    PubMed     Text format     Abstract available


  221. KIYAK CAGLAYAN E, Engin-Ustun Y, Sari N, Gocmen AY, et al
    Is there association between vitamin D levels, apelin 36, and visfatin in PCOS?
    Gynecol Endocrinol. 2016;32:386-9.
    PubMed     Text format     Abstract available


  222. AL-JAROUDI D, Al-Banyan N, Aljohani NJ, Kaddour O, et al
    Vitamin D deficiency among subfertile women: case-control study.
    Gynecol Endocrinol. 2016;32:272-5.
    PubMed     Text format     Abstract available


  223. TECHATRAISAK K, Wongmeerit K, Dangrat C, Wongwananuruk T, et al
    Measures of body adiposity and visceral adiposity index as predictors of metabolic syndrome among Thai women with PCOS.
    Gynecol Endocrinol. 2016;32:276-80.
    PubMed     Text format     Abstract available


  224. BUGGIO L, Roncella E, Somigliana E, Vercellini P, et al
    Vitamin D and benign gynaecological diseases: a critical analysis of the current evidence.
    Gynecol Endocrinol. 2016;32:259-63.
    PubMed     Text format     Abstract available


    September 2014
  225. MENDOZA N, Simoncini T, Genazzani AD
    Hormonal contraceptive choice for women with PCOS: a systematic review of randomized trials and observational studies.
    Gynecol Endocrinol. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: